[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Page 10462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03611]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-593]


Bulk Manufacturer of Controlled Substances Application: 
Scottsdale Research Institute

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 24, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on October 31, 2019, Scottsdale Research Institute, 5436 
E Tapekim Road, Cave Creek, Arizona 85331 applied to be registered as a 
bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
         Controlled  substance             code          Schedule
------------------------------------------------------------------------
Psilocybin.............................     7437  I
Psilocyn...............................     7438  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the above controlled 
substances to provide consistent medical grade active pharmaceutical 
ingredient (API) and reference standards for distribution to their 
research customers.

    Dated: January 31, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03611 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P